URG 801Alternative Names: URG-801
Latest Information Update: 14 Oct 2016
At a glance
- Originator Urigen Pharmaceuticals
- Class Urologics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Interstitial cystitis
Most Recent Events
- 07 Oct 2016 Early research in Interstitial cystitis in USA before October 2016 (Urigen Pharmaceuticals pipeline, October 2016)